sglt2 inhibitors vs glp-1 agonists Cardiorenal Protection: Potential of and Receptor in the Treatment of Type 2 Diabetes | Diabetes Therapy GLP-1 receptor agonists and SGLT2

Compounds (3,5-Odicaffeoyl-d-quinic acid and matesaponin-2 and linolenic acid exhibited significant elevations in GLP-1 levels [33]

Incidents related to aspiration or regurgitation of gastric contents after appropriate fasting, can be reported to the Canada Vigilance Program at or to ISMP Canada through the Individual Practitioner Reporting portal at The Canadian Medication Incident Reporting and Prevention System (CMIRPS) is a collaborative pan-Canadian program of Health Canada, the Canadian Institute for Health Information (CIHI), the Institute for Safe Medication Practices Canada (ISMP Canada) and Healthcare Excellence Canada (HEC)

Some women report increased hunger and cravings

3 | Broader indications for GLP-1s could be coming

Healthcare providers may adjust treatment plans or opt for alternative administration routes if concerns arise about delayed onset due to gastric issues